Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Tonix Pharm Hld (TNXP)

Tonix Pharm Hld (TNXP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
NewtoTheStreet's Newsmax Sunday 930AM EST Lineup Features Tonix Pharmaceuticals Holding Corp., Nextech AR, Winston Gold and NativeCoin

NEW YORK, NY / ACCESSWIRE / February 13, 2021 / New To The Street will broadcast Show 151 Sunday 930AM EST on NEWSMAX T.V., and on FOX Business Monday evening 1030PM PST. The show will feature Doctor Seth...

TNXP : 1.2950 (+3.60%)
NewtoTheStreet's  New to The Street's Newsmax Sunday 930AM EST lineup features Tonix Pharmaceuticals Holding Corp., Nextech AR, Winston Gold and NativeCoin

NEW YORK, NY / ACCESSWIRE / February 13, 2021 / New To The Street will broadcast Show 151 Sunday 930AM EST on NEWSMAX T.V., and on FOX Business Monday evening 1030PM PST. The show will feature Doctor Seth...

TNXP : 1.2950 (+3.60%)
Psychedelics are Gaining Traction as Therapies and Medicines

, /PRNewswire/ -- The psychedelic drug market continues to follow a similar path to the cannabis segment. It is now slowly getting more attention from investors as the stigma surrounding psychedelic drugs...

TNXP : 1.2950 (+3.60%)
RVVTF : 0.3966 (-2.70%)
ABBV : 108.16 (-0.49%)
AZN : 49.31 (-1.58%)
Tonix Pharmaceuticals Licenses Technology for Treating Prader-Willi Syndrome, a Rare Genetic Eating Disorder, from the French National Institute of Health and Medical Research (Inserm)

Expands Proprietary Uses of Tonix's Potentiated Oxytocin for Intranasal Administration

TNXP : 1.2950 (+3.60%)
Tonix Pharmaceuticals to Participate in BIO CEO & Investor Digital Conference

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, announced today that Seth Lederman, M.D., President and Chief Executive Officer of...

TNXP : 1.2950 (+3.60%)
Tonix Pharmaceuticals Holdings Corp. Closes $70M Common Stock Offering Priced At-The-Market Under Nasdaq Rules

TONIX PHARMACEUTICALS HOLDINGS CORP. (NASDAQ: TNXP) ("Tonix" or the "Company"), a clinical-stage biopharmaceutical company, today announced the closing of its previously announced registered direct offering,...

TNXP : 1.2950 (+3.60%)
Tonix Pharmaceuticals Holdings Corp. Prices $70M Common Stock Offering Priced At-The-Market Under Nasdaq Rules

TONIX PHARMACEUTICALS HOLDINGS CORP. (NASDAQ: TNXP) ("Tonix" or the "Company"), a clinical-stage biopharmaceutical company, today announced it has entered into a securities purchase agreement with institutional...

TNXP : 1.2950 (+3.60%)
Tonix Pharmaceuticals to Develop COVID-19 Skin Test (TNX-2100) to Measure SARS-CoV-2 Exposure and T Cell Immunity

Pre-IND Meeting Written Response from FDA Provides Guidance on Product Development and Clinical Testing Protocol

TNXP : 1.2950 (+3.60%)
Research and Development Moves the Psychedelics Market Forward

, /PRNewswire/ -- The ongoing surge of development and investment into psychedelic medicine and psychedelic-assisted therapy is the direct result of newfound public support and legitimacy for these revolutionary...

MYCO.CN : 0.490 (-2.00%)
NUMI.VN : 1.720 (-1.71%)
LKYSF : 1.3700 (-0.77%)
TNXP : 1.2950 (+3.60%)
HSTRF : 0.3349 (-3.24%)
MMEDF : 3.7180 (-1.64%)
Tonix Pharmaceuticals Announces Publication of Patent Application for TNX-1500 (Monoclonal Antibody Anti-CD40-Ligand) in Development for Preventing and Treating Organ Transplant Rejection and Treating Autoimmune Conditions

GMP Production of TNX-1500 is Expected to be Available in the Third Quarter of 2021

TNXP : 1.2950 (+3.60%)
Tonix Pharmaceuticals Holdings Corp. Closes $40M Common Stock Offering Priced At-the-Market Under Nasdaq Rules

TONIX PHARMACEUTICALS HOLDINGS CORP. (NASDAQ: TNXP) ("Tonix" or the "Company"), a clinical-stage biopharmaceutical company, today announced the closing of its previously announced registered direct offering,...

TNXP : 1.2950 (+3.60%)
Sidoti Virtual Investor Conference

GRYCF : 0.3767 (+5.70%)
TNXP : 1.2950 (+3.60%)
CIR : 37.34 (-1.16%)
INS : 41.89 (-3.14%)
EML : 26.05 (+0.39%)
BHR : 7.10 (-2.47%)
SWM : 48.22 (+1.09%)
VNRX : 4.30 (-2.71%)
ORN : 5.79 (-2.69%)
III : 3.70 (+0.27%)
VSEC : 39.08 (-1.90%)
OTTR : 41.64 (-0.62%)
CULP : 16.54 (+0.98%)
FORR : 45.28 (+0.44%)
Tonix Pharmaceuticals Holdings Corp. Prices $40M Common Stock Offering Priced at-the-Market Under Nasdaq Rules

TONIX PHARMACEUTICALS HOLDINGS CORP. (NASDAQ: TNXP) ("Tonix" or the "Company"), a clinical-stage biopharmaceutical company, today announced it has entered into a securities purchase agreement with institutional...

TNXP : 1.2950 (+3.60%)
Further Research into Psilocybin Opens New Doors for Treatment

, /PRNewswire/ -- Among the popular fields of study for biotech companies in recent years are gene editing, tissue engineering and regeneration, nanobiotechnology and others. In addition, new segments...

MYCOF : 0.3967 (-3.13%)
MYCO.CN : 0.490 (-2.00%)
LLY : 203.74 (-0.38%)
RVVTF : 0.3966 (-2.70%)
HSTRF : 0.3349 (-3.24%)
TNXP : 1.2950 (+3.60%)
Tonix Pharmaceuticals to Participate in Upcoming January Conferences

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, announced today that Seth Lederman, M.D., President and Chief Executive Officer of...

TNXP : 1.2950 (+3.60%)
Tonix Pharmaceuticals and Massachusetts General Hospital (MGH) Enter into Research Collaboration on Tonix's Third Generation anti-CD40-Ligand Monoclonal Antibody, TNX-1500, for the Treatment and Prevention of Kidney Transplant Rejection

Expands Ongoing Research Collaboration Between Tonix and MGH Studying TNX-1500 in Heart Transplantation

TNXP : 1.2950 (+3.60%)
Tonix Pharmaceuticals Plans Commercial Scale Vaccine Manufacturing Facility

Hamilton, MT Facility Is Planned to Manufacture Vaccines at Commercial Scale, Including Vaccines Under Development for COVID-19

TNXP : 1.2950 (+3.60%)
Tonix Pharmaceuticals Acquires Exclusive License to University of Geneva Technology for Oxytocin-Based Treatments for Treating Insulin Resistance, Diabetes and Obesity, Expanding Proprietary Uses for TNX-1900 (Intranasal Potentiated Oxytocin)

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced an agreement whereby Tonix has acquired the exclusive license to the...

TNXP : 1.2950 (+3.60%)
Psychedelics Industry Gearing Up For an Even Bigger 2021

, /PRNewswire/ -- Investments continued flowing into the psychedelic medicine sector this year and will likely continue in 2021 as mental illness cases rise across the globe. The World Health Organization...

JNJ : 163.33 (+0.46%)
TNXP : 1.2950 (+3.60%)
NUMI.VN : 1.720 (-1.71%)
LKYSF : 1.3700 (-0.77%)
CMPS : 50.84 (+1.46%)
MYCO.CN : 0.490 (-2.00%)
Tonix Pharmaceuticals Reports Topline Results from Phase 3 RECOVERY Study of TNX-102 SL in PTSD and Outlines Future Development Plans

Primary Endpoint For Full Cohort of Enrolled Participants Did Not Achieve Statistical Significance (P=0.343), Consistent with Previously Reported Interim Analysis

TNXP : 1.2950 (+3.60%)

Van Meerten Stock Picks

5 Great Small Caps
Summary 100% technical buy signals.
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar